The Virginian Pilot A Norfolk biotech startup researching treatments for a serious side effect of COVID-19 recently received another funding...
Read MoreRLS-0071 is in development for treatment of Acute Lung Injury (ALI) and Hypoxic Ischemic Encephalopathy (HIE) Norfolk, VA, May...
Read MoreProceeds to Fund Programs Addressing Acute Lung Injury (ALI) and Hypoxic Ischemic Encephalopathy (HIE) Norfolk, VA, April 28, 2021 —...
Read MoreNorfolk, VA, April 9, 2021 – ReAlta Life Sciences, Inc. announced today that Dr. Ulrich Thienel, MD, PhD, Chief Executive...
Read MoreNorfolk, VA, February 16, 2021 – ReAlta Life Sciences, Inc. (“ReAlta”), a company addressing life-threatening diseases through harnessing the power...
Read MoreNorfolk, VA, December 3, 2020 — ReAlta Life Sciences, Inc., today announced that the European Medicines Agency (EMA) has granted Orphan...
Read MoreNorfolk, VA, November 19, 2020 — Norfolk, Virginia, known globally for its expertise in resilience and strong entrepreneurship ecosystem, is...
Read MoreThe Virginia Pilot | November 16, 2020 https://www.pilotonline.com/inside-business/vp-ib-realta-covid-update-1109-20201116-hkwsno4uencqvbq7tjidj7alva-story.html
Read MoreNorfolk, VA, October 20, 2020 — ReAlta Life Sciences, Inc., today announced the details of a formal ribbon-cutting ceremony at their...
Read More